CTOs on the Move

Saint Mary`s Healthcare

www.smha.org

 
St. Mary`s Healthcare offers a continuum of services designed to fulfill the total healthcare needs of the community, while being the lowest cost provider. In addition to our 143 bed hospital, a 160 bed nursing home and a 10 bed acute rehabilitation unit, St. Mary`s provides highly accessible healthcare through its seven offsite primary care centers and behavioral health service locations throughout two counties. We treat more than 290,000 outpatient visits a year. Founded by the Sisters of St. Joseph of Carondelet in 1903, and as a member of Ascension since 2002, St. Mary`s is dedicated to improving the health ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.smha.org
  • 427 Guy Park Avenue
    Amsterdam, NY USA 12010
  • Phone: 518.842.1900

Executives

Name Title Contact Details

Similar Companies

AAAT.L.C Healthcare

AAAT.L.C Healthcare is a Encino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Target Health Inc

Target Health Inc is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Cal eConnect

Cal eConnect serves as the State's governance entity for health information exchange. As such, Cal eConnect is responsible for meeting requirements set forth in the State's grant agreement with the federal Office of the National Coordinator for Health Information Technology (ONC).

Versartis

Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.

Empiric Health

Empiric Health is a technology-enabled service platform that lowers cost and improves outcomes for health system customers through data-driven physician practice change. Empiric differentiates with a proprietary comparative analytics methodology and proven ability to change physician behavior, so that care providers can understand and optimize for high -value, episodic care. Empiric was formed by Intermountain Healthcare with assistance from Oxeon.